ANTX Insider Transactions
Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-02-23 | Easom Eric | director, officer: Chief Executive Officer | 267,650 | A-Award | A | 267,650 | 11.99 | 3,209,123.50 |
2023-02-15 | Day Lucy | officer: Chief Financial Officer | 82,300 | A-Award | A | 82,300 | 14.29 | 1,176,067.00 |
2023-02-15 | Nazak Michael Adrian | officer: Chief Accounting Officer | 16,600 | A-Award | A | 16,600 | 14.29 | 237,214.00 |
2023-02-15 | Eizen Joshua M | officer: Chief Legal Officer | 50,150 | A-Award | A | 50,150 | 14.29 | 716,643.50 |
2023-02-15 | Eckburg Paul | officer: Chief Medical Officer | 70,950 | A-Award | A | 70,950 | 14.29 | 1,013,875.50 |
2023-02-15 | Chanda Sanjay | officer: Chief Development Officer | 57,950 | A-Award | A | 57,950 | 14.29 | 828,105.50 |
2023-02-15 | Krause Kevin Michael | officer: Chief Strategy Officer | 62,200 | A-Award | A | 62,200 | 14.29 | 888,838.00 |
2022-11-14 | Easom Eric | director, officer: Chief Executive Officer | 4,907 | S-Sale | D | 23 | 15.04 | 345.92 |
2022-11-10 | Easom Eric | director, officer: Chief Executive Officer | 4,930 | S-Sale | D | 4,413 | 15.32 | 67,628.34 |
2022-11-09 | Easom Eric | director, officer: Chief Executive Officer | 4,907 | S-Sale | D | 10,111 | 15.61 | 157,846.87 |
2022-11-08 | Easom Eric | director, officer: Chief Executive Officer | 15,018 | S-Sale | D | 1,255 | 16.38 | 20,558.91 |
2022-11-08 | Easom Eric | director, officer: Chief Executive Officer | 16,273 | S-Sale | D | 5,800 | 15.41 | 89,387.86 |
2022-11-07 | Easom Eric | director, officer: Chief Executive Officer | 4,907 | S-Sale | D | 2,036 | 16.72 | 34,036.02 |
2022-11-07 | Easom Eric | director, officer: Chief Executive Officer | 6,943 | S-Sale | D | 10,167 | 15.90 | 161,705.12 |
2022-11-04 | Easom Eric | director, officer: Chief Executive Officer | 17,110 | S-Sale | D | 8,828 | 15.80 | 139,474.45 |
2022-11-03 | Easom Eric | director, officer: Chief Executive Officer | 25,938 | S-Sale | D | 3,083 | 16.02 | 49,375.79 |
2022-11-03 | Easom Eric | director, officer: Chief Executive Officer | 29,021 | S-Sale | D | 11,082 | 15.67 | 173,682.64 |
2022-11-02 | Easom Eric | director, officer: Chief Executive Officer | 4,907 | S-Sale | D | 1,544 | 15.07 | 23,262.52 |
2022-10-31 | Easom Eric | director, officer: Chief Executive Officer | 6,451 | S-Sale | D | 2,688 | 15.39 | 41,362.68 |
2022-10-28 | Easom Eric | director, officer: Chief Executive Officer | 4,907 | S-Sale | D | 1,683 | 15.09 | 25,392.43 |
2022-10-27 | Easom Eric | director, officer: Chief Executive Officer | 6,590 | S-Sale | D | 924 | 15.36 | 14,189.96 |
2022-10-26 | Easom Eric | director, officer: Chief Executive Officer | 4,907 | S-Sale | D | 1,678 | 15.10 | 25,341.99 |
2022-10-25 | Easom Eric | director, officer: Chief Executive Officer | 6,585 | S-Sale | D | 534 | 16.20 | 8,651.81 |
2022-10-25 | Easom Eric | director, officer: Chief Executive Officer | 7,119 | S-Sale | D | 4,272 | 15.69 | 67,020.42 |
2022-10-24 | Easom Eric | director, officer: Chief Executive Officer | 11,391 | S-Sale | D | 2,866 | 16.17 | 46,343.51 |
2022-10-21 | Easom Eric | director, officer: Chief Executive Officer | 4,907 | S-Sale | D | 2,350 | 16.69 | 39,231.84 |
2022-10-21 | Easom Eric | director, officer: Chief Executive Officer | 7,257 | S-Sale | D | 11,601 | 16.29 | 189,008.13 |
2022-10-20 | Easom Eric | director, officer: Chief Executive Officer | 18,858 | S-Sale | D | 31 | 17.15 | 531.50 |
2022-10-20 | Easom Eric | director, officer: Chief Executive Officer | 18,889 | S-Sale | D | 7,262 | 16.68 | 121,140.33 |
2022-10-14 | Eizen Joshua M | officer: Chief Legal Officer | 92,000 | A-Award | A | 92,000 | 17.88 | 1,644,960.00 |
2022-08-04 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 3,773,517 | P-Purchase | A | 100 | 7.99 | 799.00 |
2022-08-03 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 3,773,417 | P-Purchase | A | 1,809 | 7.48 | 13,531.32 |
2022-07-27 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 3,771,608 | P-Purchase | A | 8,281 | 7.91 | 65,502.71 |
2022-07-26 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 3,763,327 | P-Purchase | A | 14,938 | 7.71 | 115,171.98 |
2022-06-21 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 3,748,389 | P-Purchase | A | 302 | 7.99 | 2,412.98 |
2022-06-14 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 3,748,087 | P-Purchase | A | 61,424 | 7.97 | 489,401.86 |
2022-06-13 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 3,686,663 | P-Purchase | A | 20,000 | 7.90 | 158,000.00 |
2022-06-06 | Aziz Kabeer | director, 10 percent owner | 413,156 | J-Other | A | 26,511 | 15.00 | 397,665.00 |
2022-06-06 | Aziz Kabeer | director, 10 percent owner | 2,184,224 | J-Other | D | 26,511 | 15.00 | 397,665.00 |
2022-06-06 | Adjuvant Global Health Technology Fund, L.P. | 10 percent owner | 413,156 | J-Other | A | 26,511 | 15.00 | 397,665.00 |
2022-06-06 | Adjuvant Global Health Technology Fund, L.P. | 10 percent owner | 2,184,224 | J-Other | D | 26,511 | 15.00 | 397,665.00 |
2022-05-12 | Chanda Sanjay | officer: Chief Development Officer | 66,000 | A-Award | A | 66,000 | 17.28 | 1,140,480.00 |
2022-05-12 | Readnour Robin Shane | director | 20,724 | A-Award | A | 20,724 | 17.28 | 358,110.72 |
2022-05-12 | FitzPatrick Margaret M | director | 10,362 | A-Award | A | 10,362 | 17.28 | 179,055.36 |
2022-05-12 | Nazak Michael Adrian | officer: Chief Accounting Officer | 14,300 | A-Award | A | 14,300 | 17.28 | 247,104.00 |
2022-05-12 | Wong Stephanie | director | 10,362 | A-Award | A | 10,362 | 17.28 | 179,055.36 |
2022-05-12 | Martin Patricia A. | director | 10,362 | A-Award | A | 10,362 | 17.28 | 179,055.36 |
2022-05-12 | Eckburg Paul | officer: Chief Medical Officer | 66,000 | A-Award | A | 66,000 | 17.28 | 1,140,480.00 |
2022-05-12 | Spigelman Melvin K | director | 10,362 | A-Award | A | 10,362 | 17.28 | 179,055.36 |
2022-05-12 | Aziz Kabeer | director | 20,724 | A-Award | A | 20,724 | 17.28 | 358,110.72 |
2022-05-12 | Day Lucy | officer: Chief Financial Officer | 66,000 | A-Award | A | 66,000 | 17.28 | 1,140,480.00 |
2022-05-12 | Krause Kevin Michael | officer: Chief Strategy Officer | 66,000 | A-Award | A | 66,000 | 17.28 | 1,140,480.00 |
2022-05-12 | Easom Eric | director, officer: Chief Executive Officer | 225,000 | A-Award | A | 225,000 | 17.28 | 3,888,000.00 |
2022-05-12 | Marks Gilbert Lynn | director | 10,362 | A-Award | A | 10,362 | 17.28 | 179,055.36 |
2022-05-12 | Zakrzewski Joseph S | director | 10,362 | A-Award | A | 10,362 | 17.28 | 179,055.36 |
2022-05-05 | FitzPatrick Margaret M | director | 11,463 | A-Award | A | 11,463 | 18.24 | 209,085.12 |
2022-03-29 | Adjuvant Global Health Technology Fund, L.P. | 10 percent owner | 0 | C-Conversion | D | 74,230 | 0.00 | 0.00 |
2022-03-29 | Adjuvant Global Health Technology Fund, L.P. | 10 percent owner | 0 | C-Conversion | D | 74,230 | 0.00 | 0.00 |
2022-03-29 | Adjuvant Global Health Technology Fund, L.P. | 10 percent owner | 2,210,735 | P-Purchase | A | 166,666 | 15.00 | 2,499,990.00 |
2022-03-29 | Adjuvant Global Health Technology Fund, L.P. | 10 percent owner | 386,645 | C-Conversion | A | 74,230 | 0.00 | 0.00 |
2022-03-29 | Adjuvant Global Health Technology Fund, L.P. | 10 percent owner | 2,044,069 | C-Conversion | A | 392,433 | 0.00 | 0.00 |
2022-03-29 | Adjuvant Global Health Technology Fund, L.P. | 10 percent owner | 312,415 | C-Conversion | A | 312,415 | 0.00 | 0.00 |
2022-03-29 | Adjuvant Global Health Technology Fund, L.P. | 10 percent owner | 1,651,636 | C-Conversion | A | 1,651,636 | 0.00 | 0.00 |
2022-03-29 | Aziz Kabeer | director, 10 percent owner | 0 | C-Conversion | D | 74,230 | 0.00 | 0.00 |
2022-03-29 | Aziz Kabeer | director, 10 percent owner | 0 | C-Conversion | D | 74,230 | 0.00 | 0.00 |
2022-03-29 | Aziz Kabeer | director, 10 percent owner | 2,210,735 | P-Purchase | A | 166,666 | 15.00 | 2,499,990.00 |
2022-03-29 | Aziz Kabeer | director, 10 percent owner | 386,645 | C-Conversion | A | 74,230 | 0.00 | 0.00 |
2022-03-29 | Aziz Kabeer | director, 10 percent owner | 2,044,069 | C-Conversion | A | 392,433 | 0.00 | 0.00 |
2022-03-29 | Aziz Kabeer | director, 10 percent owner | 312,415 | C-Conversion | A | 312,415 | 0.00 | 0.00 |
2022-03-29 | Aziz Kabeer | director, 10 percent owner | 1,651,636 | C-Conversion | A | 1,651,636 | 0.00 | 0.00 |
2022-03-29 | Easom Eric | director, officer: Chief Executive Officer | 0 | C-Conversion | D | 4,907 | 0.00 | 0.00 |
2022-03-29 | Easom Eric | director, officer: Chief Executive Officer | 4,907 | C-Conversion | A | 4,907 | 0.00 | 0.00 |
2022-03-29 | Readnour Robin Shane | director | 0 | C-Conversion | D | 71,839 | 0.00 | 0.00 |
2022-03-29 | Readnour Robin Shane | director | 0 | C-Conversion | D | 71,839 | 0.00 | 0.00 |
2022-03-29 | Readnour Robin Shane | director | 487,592 | P-Purchase | A | 82,618 | 15.00 | 1,239,270.00 |
2022-03-29 | Readnour Robin Shane | director | 417,363 | P-Purchase | A | 70,716 | 15.00 | 1,060,740.00 |
2022-03-29 | Readnour Robin Shane | director | 404,974 | C-Conversion | A | 71,839 | 0.00 | 0.00 |
2022-03-29 | Readnour Robin Shane | director | 346,647 | C-Conversion | A | 61,491 | 0.00 | 0.00 |
2022-03-29 | Readnour Robin Shane | director | 333,135 | C-Conversion | A | 333,135 | 0.00 | 0.00 |
2022-03-29 | Readnour Robin Shane | director | 285,156 | C-Conversion | A | 285,156 | 0.00 | 0.00 |
2022-03-29 | Zakrzewski Joseph S | director | 0 | C-Conversion | D | 98,199 | 0.00 | 0.00 |
2022-03-29 | Zakrzewski Joseph S | director | 98,199 | C-Conversion | A | 98,199 | 0.00 | 0.00 |
2022-03-29 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 0 | C-Conversion | D | 299,999 | 0.00 | 0.00 |
2022-03-29 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 415,612 | P-Purchase | A | 115,613 | 15.00 | 1,734,195.00 |
2022-03-29 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 299,999 | C-Conversion | A | 299,999 | 0.00 | 0.00 |
2022-03-29 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 3,251,051 | P-Purchase | A | 1,551,053 | 15.00 | 23,265,795.00 |
2022-03-29 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 1,699,998 | C-Conversion | A | 1,699,998 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.